arrow
H

Hirofumi Chiba

Sapporo Medical University School of Medicine
H指数:31
被引数:3,869

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Time-dependent impact of programmed death-ligand 1 expression on early progression and long-term response to first-line osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer

程序性死亡配体1表达对表皮生长因子受体突变非小细胞肺癌患者一线奥希替尼早期进展和长期反应的时间依赖性影响

2026-09-210
OA
Altered balance between circulating T follicular helper and T peripheral helper cells and regulatory B cells in COPD: an exploratory cross-sectional study

COPD患者循环T滤泡辅助细胞和T外周辅助细胞以及调节性B细胞平衡的改变:一项探索性横断面研究

2026-09-100
OA
The providing multidisciplinary ILD diagnoses (PROMISE) study – study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis

提供多学科ILD诊断(PROMISE)研究——日本国家注册研究的设计,促进互动式在线多学科讨论诊断

2026-04-060
OAAI
Upfront combination therapy with nintedanib and antiinflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)
2026-02-163
PRE
Screening for lung fibrosis using serum surfactant protein-D, KL-6, and a deep learning algorithm on chest radiographs: a prospective observational study

使用血清表面活性蛋白-D、KL-6和胸部X光片上的深度学习算法进行肺纤维化筛查:一项前瞻性观察性研究

2025-12-170
OAAI
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study

纳武利尤单抗和伊匹木单抗联合或未联合化疗治疗不可切除非小细胞肺癌的疗效与安全性:一项多中心回顾性观察研究

2025-01-031
OA
Effect of telomere length and TERT/TERC rare variants on survival in Japanese patients with idiopathic interstitial pneumonias :Genetic predisposition study from the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry (NEJ036A)
2024-10-300
PRE
Esophagomediastinal fistula during durvalumab plus tremelimumab with chemotherapy in angiotensin-converting enzyme 2-positive non-small cell lung cancer: a case report

durvalumab联合tremelimumab联合化疗治疗血管紧张素转换酶2阳性非小细胞肺癌期间食管纵隔瘘: 一例病例报告

2024-10-010
OAAI
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
2024-04-080
OAAI
Bob1 maintains T follicular helper cells for long-term humoral immunity
2024-02-155
OAAI
Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases
2023-11-242
OAAI
Nationwide All ILD registry with central MDD in Japan; Providing Multidisciplinary ILD diagnoses (PROMISE) study.
2023-10-271
PRE